The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; none of the 37 sources its claims cite is checked for support yet.
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes
Open accessPublished version of a preprint
Abstract
Pericytes put the squeeze on cognition: Like a computer, the brain needs a reliable source of power, which is provided as oxygen and glucose in the blood. However, in many neurological disorders this energy supply is disrupted. Brain blood flow is controlled by adjustment of the diameters of the vessels supplying the blood. Nortley et al. found that, both in humans developing Alzheimer's disease (AD) and in a mouse model of AD, brain capillaries become squeezed by pericytes (see the Perspective by Liesz). By defining the underlying mechanism, they suggest potential targets for therapy in early AD. Science , this issue p. eaav9518 ; see also p. 223
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Amyloid β oligomers constrict human and rodent brain capillaries at pericyte locations via reactive oxygen species, endothelin-1, and pericyte ETA receptors. In human cognitive-decline biopsies and an AD mouse model, this pericyte-mediated capillary constriction is predicted to substantially reduce cerebral blood flow and can be reversed by C-type natriuretic peptide.
Key findings
- Soluble Aβ1–42 constricted all 4 human capillaries tested by ~25% after 40 min (p=0.01); in rat slices, 16/20 capillaries (80%) constricted >5%, reaching ~15% after 1 h (p=0.006), with an apparent EC50 of 4.7 nM.
- The Aβ-evoked constriction was blocked by ETA receptor blocker BQ-123 (p=0.008), SOD1 (p=3.7×10⁻⁶), NADPH oxidase inhibitor DPI (p=0.032), and NOX4 blocker GKT137831 (p=0.0011); NOX2 blocker ebselen reduced it by only 45%. Aβ increased ROS in pericytes 7.28-fold (p=0.001) versus 1.76-fold in Iba1-expressing immune cells (p=0.05), giving 6.4-fold more total ROS generation by pericytes.
- In rapidly fixed biopsies from 13 living patients with cognitive decline, 7 had Aβ deposition and 6 did not. Mean capillary diameter was 8.1% smaller with Aβ deposition (p=0.0007); near pericyte somata, diameter was ~25% larger in no-Aβ patients (p=3.7×10⁻⁷) but ~30% smaller in Aβ-deposition patients (p=1.6×10⁻²⁰), predicted to reduce flow by ~50% (Discussion; Methods calculation gives 58%).
- In APPNL-G-F AD mice in vivo, capillary diameter was smaller (p=1.7×10⁻⁹) and more strongly reduced at pericyte somata (p=1.6×10⁻¹⁷), while arterioles and venules were not constricted; cerebellar capillaries showed no constriction. CNP (100 nM) reversed Aβ-evoked capillary constriction (p=0.029), whereas combined NOX4 + ETA blockade prevented further constriction (p=0.027) but did not reverse diameter to baseline within 1 h.
Methods
- Live human cortical slices from neurosurgical tumour-access tissue, rapidly fixed human cortical biopsies from patients with cognitive decline, rat cortical slices, and APPNL-G-F × NG2-DsRed mice were used; methods included immunohistochemistry, two-photon imaging, pericyte Ca²⁺ imaging, ROS/GSH imaging, propidium iodide death assays, and pimonidazole hypoxia labelling.
- Capillary diameters were measured blinded to Aβ status, often as a function of distance from PDGFRβ-labelled pericyte somata; analyses used t-tests, Mann-Whitney tests, linear regression slopes, and Holm-Bonferroni correction.
- Flow effects were estimated from Poiseuille’s law, assuming pericytes spaced at 2L and capillary constriction near somata.
Limitations
- Stated: limited live human tissue precluded detailed mechanistic analysis; the authors cannot rule out that ETA receptors are on a different cell type; the Aβ deposition measure may largely reflect plaques; GSH changes cannot be converted to ROS synthesis rates; future work is needed on ageing humans who accumulate Aβ without AD and on ET receptor affinity in AD mice.
- Evident from the text: human biopsy data come from a small cohort (13 patients; subgroups of 6 no Aβ, 3 moderate, 4 severe), live human slice data are very limited (94 pericytes from 2 patients; 4 capillaries for Aβ), most mechanistic work is in rat slices, and the in vivo AD mouse data are from ~4-month-old mice.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 37 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the processes of 36% of pericytes labeled for α smooth muscle actin (Fig. 1D)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Applying soluble Aβ1−42 (oligomeric + monomeric, 72 nM calculated from the monomeric MW) to human brain slices evoked a slowly developing constriction of all 4 capillaries tested, which reduced their diameter by ~25% after 40 mins (Fig. 1H, significantly reduced, p=0.01).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ1−42 evoked a constriction of rat capillaries near pericyte locations”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“hypoxic tissue labeling by pimonidazole (hypoxyprobe) was increased significantly in vivo in the AD mice (Fig. S7).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Hypoxia is increased in the AD cortex
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and the diameter at pericyte somata was more strongly reduced (Fig. 5E, p=1.6x10-17).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in vivo in AD mice
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The Aβ1−42-evoked capillary constriction in rat cortical slices was blocked by the endothelin-1 (ET) type A receptor blocker BQ-123 (1 μM, p=0.008, Fig. 2E, G)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“whereas the NOX2 blocker ebselen (2 μM) reduced the constriction by only 45% (n=8, p=0.027”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In patients with no detectable Aβ deposition the capillary diameter increased at locations near pericyte somata compared to at locations far from the somata (~25% larger, slope of line is significantly less than zero, p=3.7x10-7 for 813 data points from 6 such patients, Fig. 4D).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in human cognitive decline patients with Aβ deposition
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we found no significant change in capillary density (12% larger in subjects depositing Aβ, p=0.56, see Materials and Methods).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in human cognitive decline patients with Aβ deposition
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ET still evoked a constriction in the presence of SOD1 (p=1.3x10-8, Fig. 2I)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 24
- Probably not a substantial claim. 32
In the paper
“The mean distance between human pericytes was 65.3±0.4 μm (for 94 pericytes imaged in tissue from 2 patients), 30% larger than in rodents (19).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
What the sources say
- Not checked yetcites [19] Hall CN Reynell C Gesslein B Hamilton NB Mishra A Sutherland BA O’Farrell FM Buchan AM Lauritzen M Attwell D Capillary pericytes regulate cerebral blood flow in health and disease Nature 2014 508 55 60 24670647 PMC3976267 source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“superfused noradrenaline constricted and glutamate dilated the capillaries at pericyte locations (Fig. 1E, F).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Capillaries monitored for an hour without applying Aβ, or those to which a version of Aβ1−42 with a scrambled sequence was applied (prepared as for the Aβ oligomers), showed no significant diameter change (Fig. 2C, G).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ1−42 (72 nM, applied for 40 mins) evoked an increase in ROS level that was suppressed by the presence of SOD1 (Fig. 3A, B).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ increased ROS production in pericytes by a factor of 7.28 (p=0.001) and in immune (Iba1-expressing) cells by a factor of 1.76 (p=0.05).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This prevented further constriction evoked by Aβ(p=0.027), but did not reverse the capillary diameter to its baseline value on a 1 hour time scale (Fig. 6A).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reversal of Aβ-evoked capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which was blocked by the ETA blocker BQ-123 (1 μM, p=2.6x10-11), but not by the ETB blocker BQ-788 (1 μM, p=0.91, Fig. 2H).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ (72 nM for 40 mins) reduced the GSH level in pericytes by 20% and in microglia by 55% (Fig. S4, p=0.014 and p=2x10-29 respectively).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In cerebellum, both WT and AD mice (n=3 each) showed a larger capillary diameter near pericyte somata (Fig. 5G, p=0.002), with no evidence for a constriction in the AD mice.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in vivo in AD mice
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“applying ET (10 nM) evoked a rise in [Ca2+]i while aCSF had no effect (Fig. 2K-L).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, applying these agents alone did not affect capillary diameter (changes after 1 hour were: BQ-123, -0.7±5.2%, n=13, p=0.9; SOD1, 3.4±5.8%, n=9, p=0.57; DPI, -7.4±3.2%, n=5, p=0.082).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It was not possible to make pure monomeric preparations of Aβ1-42 or Aβ1-40.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Oligomerising Aβ and assessing the form and concentration of Aβ applied
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Healthy capillaries (<10 μm in diameter, mean diameter 5.61±0.03 μm (n=299) in rat, and 5.08±0.33 μm (n=12) in human, with no rings of arteriolar smooth muscle around them) were selected as previously described (41)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging capillaries in brain slices
Strength:plain· not yet calibratedn = 12Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ1-42 and Aβ1-40 formed monomers and oligomers, while scrambled Aβ1-42 formed mainly monomers (Fig. 1G).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Oligomerising Aβ and assessing the form and concentration of Aβ applied
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Healthy capillaries (<10 μm in diameter, mean diameter 5.61±0.03 μm (n=299) in rat, and 5.08±0.33 μm (n=12) in human, with no rings of arteriolar smooth muscle around them) were selected as previously described (41)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging capillaries in brain slices
Strength:plain· not yet calibratedn = 299Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean age of patients without Aβ deposition was 50.5±5.5 (n=6, 4 women and 2 men), and of those with Aβ deposition was 62.1±4.2 (n=7, 4 women and 3 men, not significantly different, p=0.11).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human biopsy data
Strength:plain· not yet calibratedn = 7Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mice aged ~4 months (P119-P143, not significantly different for WT and AD, p=0.13) were anesthetised using urethane (1.55 g/kg given in two doses 15 minutes apart).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Experiments in vivo on AD mice
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Regressing mean capillary diameter against age from all patients, or from the patients lacking Aβ deposition, showed that there was no significant dependence on age (p=0.5 and p=0.82 respectively).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human biopsy data
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Cerebral blood flow in the grey matter can be reduced by over 40% (3)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [3] Asllani I Habeck C Scarmeas N Borogovac A Brown TR Stern Y Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease J Cereb Blood Flow Metab 2008 28 725 736 17960142 PMC2711077 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“reduced blood flow increases Aβ production (13, 14).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [13] Sun X He G Qing H Zhou W Dobie F Cai F Staufenbiel M Huang LE Song W Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression Proc Natl Acad Sci USA 2006 103 18727 18732 17121991 PMC1693730 source
- Not checked yetcites [14] Zhang X Zhou K Wang R Cui J Lipton SA Liao FF Xu H Zhang YW Hypoxia-inducible factor 1α(HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation J Biol Chem 2007 282 10873 10880 17303576 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A subset of pericytes on capillary walls is contractile (these are the only contractile cells on capillaries (18))”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [18] Peppiatt CM Howarth C Mobbs PG Attwell D Bidirectional control of CNS capillary diameter by pericytes Nature 2006 443 700 704 17036005 PMC1761848 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Aβ1−42 oligomers, the molecular species believed to be responsible for Aβ’s toxic effects in AD (22, 23).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [22] Klein WL Krafft GA Finch CE Targeting small Aβ oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci 2001 24 219 224 11250006
- Not checked yetcites [23] Attems J Lintner F Jellinger KA Amyloid β peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology Acta Neuropathol 2004 107 283 291 14986026
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“Exogenous amyloid β can reduce cerebral blood flow (10–12)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [10] Suo Z Humphrey J Kundtz A Sethi F Placzek A Crawford F Mullan M Soluble Alzheimer’s β-amyloid constricts the cerebral vasculature in vivo Neurosci Lett 1998 257 77 80 9865931
- Not checked yetcites [11] Deane R Du Yan S Submamaryan RK LaRue B Jovanovic S Hogg E Welch D Manness L Lin C Yu J Zhu H RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain Nat Med 2003 9 907 913 12808450 source
- Not checked yetcites [12] Dietrich HH Xiang C Han BH Zipfel GJ Holtzman DM Soluble amyloid-beta, effect on cerebral arteriolar regulation and vascular cells Molec Neurodegen 2010 5 15 PMC2873254 20388225
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the cells showing the brightest oxidised dihydroethidium fluorescence were located on capillaries, had the morphology of pericytes, and labeled for NG2 but not Iba1 (Fig. 3C), implying that they are pericytes.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For each z-stack, a mean intensity per pericyte or Iba-1-labeled cell, and the total intensity per population of pericytes or Iba1-labeled cells, were calculated, and analysis was performed using the z-stack as the statistical unit.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging ROS production
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The work on fresh living human brain tissue received ethical approval from the National Health Service (REC number 15/NW/0568) and all patients gave informed consent.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human brain slices
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“Cellular production of reactive oxygen species (ROS) in brain slices was visualised through the O2.-specific oxidation of dihydroethidium to ethidium, which binds to the DNA and RNA of O2.-producing cells (46).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging ROS production
What the sources say
- Not checked yetcites [46] Wu L-J Wu G Akhavan Sharif MR Baker A Jia Y Fahey FH Luo HR Feener EP Clapham DE The voltage-gated proton channel, Hv1, enhances brain damage from ischemic stroke Nat Neurosci 2012 15 565 573 22388960 PMC3314139 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“C-type natriuretic peptide (CNP), which can reverse ET-mediated effects (36) by blocking Ca2+ release from internal stores and activating myosin light chain phosphatase (Fig. S8).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reversal of Aβ-evoked capillary constriction
What the sources say
- Not checked yetcites [36] Špiranec K Chen W Werner F Nikolaev VO Naruke T Koch F Werner A Eder-Negrin P Diéguez-Hurtado R Adams RH Baba HA Endothelial C-type natriuretic peptide acts on pericytes to regulate microcirculatory flow and blood pressure Circulation 2018 138 494 508 29626067 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“In some experiments pericytes were identified prior to imaging by incubating slices for 30 min in 10 μg/ml isolectin B4 conjugated to Alexa 488 or 568 (ThermoFisher I21411 or 121412), which binds to α-D-galactose residues in the basement membrane generated by pericytes and endothelial cells, and outlines pericytes (41).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging capillaries in brain slices
What the sources say
- Not checked yetcites [41] Mishra A O’Farrell FM Reynall C Hamilton NB Hall CN Attwell D Imaging pericytes and capillary diameter in brain slices and isolated retinae Nat Protoc 2014 9 323 336 24434801
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Throughout this work pericytes were identified by their morphology (spatially isolated cells located outside capillaries) as confirmed by isolectin B4 labelling, or by antibody labelling for their characteristic marker PDGFRβ, or by expression of dsRed under the NG2 promoter.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“with the experimenter blinded to the occurrence of Aβ deposition (viewing only the PDGFRβ image channel)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in human cognitive decline patients with Aβ deposition
Strength:plain· not yet calibratedn = 13Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Oligodendrocyte precursor cells (OPCs), identified based on a star-like morphology and weaker baseline fluorescence, and arteriolar smooth muscle cells, were excluded from the analysis.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging pericyte [Ca2+]i
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“No preincubation with DHE was used, to limit the intracellular accumulation of oxidised product.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging ROS production
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Capillary diameter was measured from the resulting movies, by an analyst blinded to the time and identity of drug application, by placing a line across the lumen on magnified images using Metamorph software.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging capillaries in brain slices
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Pericyte responses to noradrenaline and glutamate as documented in Fig. 1 were observed whether or not there was tumour infiltration.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human brain slices
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“To avoid counting cells killed by the slicing procedure, quantification of the percentage of pericytes that were dead excluded cells within 20 μm of the slice surface.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Assessing pericyte death
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ was only applied to slices that showed no tumour infiltration.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human brain slices
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“Capillary constriction by pericytes may explain why some capillaries become occluded by neutrophils in AD (37)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Discussion
What the sources say
- Not checked yetcites [37] Roberts BR Lind M Wagen AZ Rembach A Frugier T Li QX Ryan TM McLean CA Doecke JD Rowe CC Villemagne VL Biochemically-defined pools of amyloid-β in sporadic Alzheimer’s disease: correlation with amyloid PET Brain 2017 140 1486 1498 28383676
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Adequate anesthesia was ensured by confirming the absence of a withdrawal response to a paw pinch.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Experiments in vivo on AD mice
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Data normality was assessed with Shapiro-Wilk or D'Agostino-Pearson omnibus tests.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Statistics
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“P values were corrected for multiple comparisons using a procedure equivalent to the Holm-Bonferroni method (for N comparisons, the most significant p value is multiplied by N, the 2nd most significant by N-1, the 3rd most significant by N-2, etc.; corrected p values are significant if they are less than 0.05).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Statistics
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The dura was left intact, to reduce perturbation of the brain.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Experiments in vivo on AD mice
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“AD mice, in which APP with a humanised Aβ region containing 3 AD-related mutations (APPNL-G-F) is knocked in (49), to avoid artefacts associated with over-expressing APP, were crossed with NG2-DsRed mice in which pericytes express DsRed (19).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Experiments in vivo on AD mice
What the sources say
- Not checked yetcites [49] Saito T Matsuba Y Mihira N Takano J Nilsson P Itohara S Iwata N Saido TC Single App knock-in mouse models of Alzheimer's disease Nat Neurosci 2014 1 661 663 24728269 source
- Not checked yetcites [19] Hall CN Reynell C Gesslein B Hamilton NB Mishra A Sutherland BA O’Farrell FM Buchan AM Lauritzen M Attwell D Capillary pericytes regulate cerebral blood flow in health and disease Nature 2014 508 55 60 24670647 PMC3976267 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“The sections were additionally immunolabeled with a GSH-NEM antibody (Millipore MAB3194, 1:500) which is specific to this adduct, allowing quantification of reduced glutathione after reaction with NEM (47).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging ROS production
What the sources say
- Not checked yetcites [47] Won SJ Kim JE Cittolin-Santos GF Swanson RA Assessment at the single-cell level identifies neuronal glutathione depletion as both a cause and effect of ischemia-reperfusion oxidative stress J Neurosci 2015 35 7143 7152 25948264 PMC4420782
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Although this measure of Aβ may largely reflect the presence of plaques, it is likely that the soluble Aβ concentration correlates with plaque load (48).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human biopsy data
What the sources say
- Not checked yetcites [48] Murphy MP Levine H III Alzheimer’s disease and the β-amyloid peptide J Alzheimer’s Dis 2010 19 311 323 20061647 PMC2813509
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Images were analysed to assess capillary diameter with the experimenter blinded to the level of Aβ deposits (i.e. viewing only the PDGFRβ channel: the condition of the tissue was sometimes worse for patients with Aβ deposition, but it was not possible to unambiguously decide whether the patient had Aβ deposition without viewing the Aβ channel).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human biopsy data
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“An estimate of the sample size needed for a typical experiment is as follows: For a control response of 100%, a response standard deviation of 10%, a response in a drug of 70% (30% inhibition), a power of 80% and p<0.05, less than 6 vessels are needed in each of the control and drug groups (www.biomath.info/power/ttest.htm).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Statistics
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“the contractility of capillary pericytes decreases for higher branching orders of capillary (19)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Calculation of effect of vessel constriction on flow
What the sources say
- Not checked yetcites [19] Hall CN Reynell C Gesslein B Hamilton NB Mishra A Sutherland BA O’Farrell FM Buchan AM Lauritzen M Attwell D Capillary pericytes regulate cerebral blood flow in health and disease Nature 2014 508 55 60 24670647 PMC3976267 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In reality the flow reduction could be greater than this because Poiseuille’s law does not apply for small capillary diameters for which the effective blood viscosity increases as the diameter decreases below 10 μm (50).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Calculation of effect of vessel constriction on flow
What the sources say
- Not checked yetcites [50] Pries AR Secomb TW Gaehtgens P Gross JF Blood flow in microvascular networks. Experiments and simulation Circ Res 1990 67 826 834 2208609
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The authors state this as an assumption.
The ETA receptors involved in ET-evoked pericyte constriction are located on the pericytes themselves.
“We assume that the ETA receptors involved are located on the pericytes themselves, since ET raised the [Ca2+]i in pericytes, but we cannot rule out the possibility that they are on a different cell type.”
The paper relies on this without support.
The soluble Aβ concentration correlates with plaque load.
“although this measure of Aβ may largely reflect the presence of plaques, it is likely that the soluble Aβ concentration correlates with plaque load”
The paper relies on this without support.
In humans, the cerebellum is relatively spared of amyloid plaque pathology.
“an area that is relatively spared of amyloid plaque pathology in humans”
The authors state this as an assumption.
Pericytes are regularly spaced on capillaries at an interval of 2L.
“We assume that pericytes are regularly spaced on capillaries at an interval of 2L.”
The authors state this as an assumption.
Flow in capillaries is governed by Poiseuille's law.
“For flow governed by Poiseuille’s law, the resistance of a segment of capillary of length L (from a pericyte soma to midway between two pericytes) and radius r1 is given by k.L/r14 where k is a constant.”
The authors state this as an assumption.
The reduction in capillary diameter from the midpoint between pericytes to the pericyte soma is linear with distance.
“then if this reduction is linear with distance the resistance of the capillary segment from the soma to the midpoint is given by k.L.(r12+r1.r2+r22)/(3.r13r23)”
The authors state this as an assumption.
The pressure is fixed at the pial end of penetrating arterioles and venules.
“if the pressure is fixed at the pial end of penetrating arterioles and venules”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Such recovery of neuron and NVU morphology is associated with the improvement of neurovascular coupling as indicated by a whisker pad electrical stimulation and laser speckle contrast imaging (LSCI) experiment (Figure 6f).[ 37 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [37]
Experimental — accuracy not yet measuredIn the citing paper
“A recent study shows that the presence of Aβ also causes capillary constriction in human cortical slices by acting on pericytes to generate reactive oxygen species (ROS) leading to endothelin-1 release”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Nortley et al., 2019
In the citing paper
“Similarly, a recent study has suggested that NOX4 in pericytes is the major source of ROS which is involved in the constriction of capillaries early in the response to Aβ [48].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
EC50 result is assigned to two different figures
MinorThe results section places the 4.7 nM EC50 in Fig. 2D, but the methods section says the same measurement is in Fig. 1D. Elsewhere, Fig. 1D is identified as showing α-smooth-muscle-actin labeling of pericytes.
“Thus, the measured EC50 of 4.7 nM for the effect of Aβ1-42 on constriction in Fig. 1D”
“The pericyte-mediated constriction evoked by Aβ1−42 showed a Michaelis-Menten dependence on Aβ concentration, with an apparent EC50 (Km) of 4.7 nM (Fig. 2D).”
Citations
Cites
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · cited 2×
“These data suggest that NOX4 in pericytes or endothelial cells (27–29), rather thanNOX2 in immune cells (28, 29), is the NADPH oxidase mainly responsible for generating the ROS that evoke capillary constriction.”
BackgroundThe precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Molecular Architecture of the Mouse Nervous System
Zeisel, A., Hochgerner, H., Lönnerberg, P., Johnsson, A., Memic, F., van der Zwan, J., Häring, M., Braun, E., Borm, L. E., La Manno, G., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.021 · Cited by 2,552
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Capillary pericytes regulate cerebral blood flow in health and disease
Hall, C. N., Reynell, C., Gesslein, B., Hamilton, N. B., Mishra, A., Sutherland, B. A., O’Farrell, F. M., Buchan, A. M., Lauritzen, M., & Attwell, D. (2014) · Nature · doi:10.1038/nature13165 · Cited by 1,870
Self-citationThe Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426
Single App knock-in mouse models of Alzheimer’s disease
Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata, N., & Saido, T. C. (2014) · Nature Neuroscience · doi:10.1038/nn.3697 · Cited by 1,366 · cited 1×
“AD mice, in which APP with a humanized Ab region containing three AD-related mutations (App) is knocked in (49) to avoid artifacts associated with overexpressing APP, were crossed with NG2-DsRed mice in which pericytes express DsRed (19).”
BackgroundSelf-citation
Flagged first, then by citations
Cited by
Sorted by citations
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
“A recent study shows that the presence of Aβ also causes capillary constriction in human cortical slices by acting on pericytes to generate reactive oxygen species (ROS) leading to endothelin-1 release (Nortley et al., 2019).”
Synergy between amyloid-β and tau in Alzheimer’s disease
Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242
APOE and Alzheimer’s disease: Advances in genetics, pathophysiology, and therapeutic approaches
Serrano-Pozo, A., Das, S., & Hyman, B. T. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30412-9 · Cited by 1,037
Comparative cellular analysis of motor cortex in human, marmoset and mouse
Bakken, T. E., Jorstad, N. L., Hu, Q., Lake, B. B., Tian, W., Kalmbach, B. E., Crow, M., Hodge, R. D., Krienen, F. M., Sorensen, S. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03465-8 · Cited by 812
Park, M. W., Cha, H. W., Kim, J., Kim, J. H., Yang, H., Yoon, S., Boonpraman, N., Yi, S. S., Yoo, I. D., & Moon, J.-S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101947 · Cited by 683
“Similarly, a recent study has suggested that NOX4 in pericytes is the major source of ROS which is involved in the constriction of capillaries early in the response to Aβ [48].”
BackgroundRevisiting the neurovascular unit
Schaeffer, S. M., & Iadecola, C. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00904-7 · Cited by 699
Half a century of amyloids: past, present and future
Ke, P. C., Zhou, R., Serpell, L. C., Riek, R., Knowles, T. P. J., Lashuel, H. A., Gazit, E., Hamley, I. W., Davis, T. P., Fändrich, M., et al. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00199a · Cited by 577
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
“…has been associated with (1) Aβ accumulation in the wall of brain vessels in the form of cerebral Aβ angiopathy 407 ; (2) brain pericyte contraction 408 ; (3) clotting of blood vessels by neutrophils 371,372 ; (4) infiltration of peripheral immune cells in the brain parenchyma 409 in response to…”
Brain capillary pericytes exert a substantial but slow influence on blood flow
Hartmann, D. A., Berthiaume, A., Grant, R. I., Harrill, S. A., Koski, T., Costello, J., Tieu, T., McDowell, K. P., Faino, A., Kelly, A., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00793-2 · Cited by 403
Mechanisms of cognitive dysfunction in CKD
Viggiano, D., Wagner, C. A., Martino, G., Nedergaard, M., Zoccali, C., Unwin, R., & Capasso, G. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0266-9 · Cited by 392
Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration
Andersen, J. V., Markussen, K. H., Jakobsen, E., Schousboe, A., Waagepetersen, H. S., Rosenberg, P. A., & Aldana, B. I. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108719 · Cited by 392
“AD is further characterized by imbalances of neuronal signaling, reduced cerebral blood flow, impaired brain energy metabolism and mitochondrial dysfunction (Busche and Konnerth, 2016; Cardoso et al., 2016; Gordon et al., 2018; Moreira et al., 2010; Nortley et al., 2019).”
Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease
Korte, N., Nortley, R., & Attwell, D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02215-w · Cited by 365
Self-citationNew Insights Into the Pathogenesis of Alzheimer's Disease
Fan, L., Mao, C., Hu, X., Zhang, S., Yang, Z., Hu, Z., Sun, H., Fan, Y., Dong, Y., Yang, J., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2019.01312 · Cited by 362
“The vasoconstrictionmechanism described suggests that there are some potential therapies for the early treatment of AD, such as the NOX4 inhibitor GKT137831 and the vasodilator C-type natriuretic peptide (CNP) (111), which can prevent the contraction of blood vessels.”
BackgroundInfluentialMicroglial metabolic flexibility supports immune surveillance of the brain parenchyma
Bernier, L., York, E. M., Kamyabi, A., Choi, H. B., Weilinger, N. L., & MacVicar, B. A. (2020) · Nature Communications · doi:10.1038/s41467-020-15267-z · Cited by 316
Endothelin: 30 Years From Discovery to Therapy
Barton, M., & Yanagisawa, M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12105 · Cited by 316
Challenges and hopes for Alzheimer’s disease
Tatulian, S. A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.016 · Cited by 291
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Immunometabolism in the Brain: How Metabolism Shapes Microglial Function
Bernier, L., York, E. M., & MacVicar, B. A. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.08.008 · Cited by 308
Cellular senescence at the crossroads of inflammation and Alzheimer's disease
Guerrero, A., De Strooper, B., & Arancibia-Cárcamo, I. L. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.06.007 · Cited by 236
Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia
Uemura, M. T., Maki, T., Ihara, M., Lee, V. M. ‐., & Trojanowski, J. Q. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00080 · Cited by 246
“In rat brains, Aβ oligomer-induced ROS triggers the release of ET1 to stimulate pericytes contraction and CBF reduction (Nortley et al., 2019).”
BackgroundInfluentialZloković, B. V., Gottesman, R. F., Bernstein, K. E., Seshadri, S. S., McKee, A. C., Snyder, H. M., Greenberg, S. M., Yaffe, K. S., Schaffer, C. B., Yuan, C., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12157 · Cited by 252
Cognitive impact of COVID-19: looking beyond the short term
Miners, J. S., Kehoe, P. G., & Love, S. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00744-w · Cited by 261
“These clinical observations are supported by experimental studies showing that brain ischaemia accelerates Aβ accumulation, through a combination of dysregulated processing of amyloid-β precursor protein (APP) and impaired Aβ clearance (reviewed [87]) and that, in turn, Aβ peptides mediate vasoconstriction, by inducin…”
BackgroundBlood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212
“A β -pericytes signaling causes vascular constriction and decreases CBF through ROS generation in humans and rodents [153].”
BackgroundPericyte Control of Blood Flow Across Microvascular Zones in the Central Nervous System
Hartmann, D. A., Coelho‐Santos, V., & Shih, A. Y. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061121-040127 · Cited by 216
“Recently,Nortley et al.(104) showed in rodent and human tissues that A β -induced reactive oxygen PH84CH10_Shih ARjats.cls October 13, 2021 15:58 species promote the release of ET-1, which binds to endothelin receptor A on pericytes, leading to aberrant sustained contraction.”
BackgroundTranscriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation
Mendiola, A. S., Ryu, J. K., Bardehle, S., Meyer-Franke, A., Ang, K. K.-H., Wilson, C., Baeten, K. M., Hanspers, K., Merlini, M., Thomas, S., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0654-0 · Cited by 199
Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration
Pluvinage, J. V., & Wyss-Coray, T. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0255-9 · Cited by 191
Chen, T., Dai, Y., Hu, C., Lin, Z., Wang, S., Yang, J., Zeng, L., Li, S., & Li, W. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00557-1 · Cited by 205
Shaw, K., Bell, L., Boyd, K., Grijseels, D. M., Clarke, D., Bonnar, O., Crombag, H. S., & Hall, C. N. (2021) · Nature Communications · doi:10.1038/s41467-021-23508-y · Cited by 198
Alzheimer’s Disease: The Link Between Amyloid-β and Neurovascular Dysfunction
Solis, E., Hascup, K. N., & Hascup, E. R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200473 · Cited by 192
Precapillary sphincters maintain perfusion in the cerebral cortex
Grubb, S., Cai, C., Hald, B. O., Khennouf, L., Nielsen, R. M., Jensen, A. G. K., Fordsmann, J. C., Zambach, S. A., & Lauritzen, M. (2020) · Nature Communications · doi:10.1038/s41467-020-14330-z · Cited by 177
Self-citationVascular contributions to Alzheimer's disease
Eisenmenger, L. B., Peret, A., Famakin, B. M., Spahic, A., Roberts, G. S., Bockholt, J. H., Johnson, K. M., & Paulsen, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.12.003 · Cited by 183
Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer’s disease
Sun, N., Akay, L. A., Murdock, M. H., Park, Y., Galiana-Melendez, F., Bubnys, A., Galani, K., Mathys, H., Jiang, X., Ng, A. P., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01334-3 · Cited by 186
“We also found no statistically significant differences in vascular fractions between this which is consistent with loss of neuronal signal sensing and impaired blood flow control in AD PERs 16,17 .”
Harris, S. S., Wolf, F., De Strooper, B., & Busche, M. A. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.005 · Cited by 161
Recent advances in the modeling of Alzheimer’s disease
Sasaguri, H., Hashimoto, S., Watamura, N., Sato, K., Takamura, R., Nagata, K., Tsubuki, S., Ohshima, T., Yoshiki, A., Sato, K., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.807473 · Cited by 157
Self-citationBlood–brain barrier link to human cognitive impairment and Alzheimer’s disease
Barisano, G., Montagne, A., Kisler, K., Schneider, J. A., Wardlaw, J. M., & Zlokovic, B. V. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-021-00014-4 · Cited by 157
Pericytes in the disease spotlight
van Splunder, H., Villacampa, P., Martínez-Romero, A., & Graupera, M. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.06.001 · Cited by 167
Insights into Alzheimer’s disease from single-cell genomic approaches
Murdock, M. H., & Tsai, L.-H. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01222-2 · Cited by 148
NADPH oxidase family proteins: signaling dynamics to disease management
Begum, R., Thota, S., Abdulkadir, A. S., Kaur, G., Bagam, P., & Batra, S. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00858-1 · Cited by 164
“Nortley et al. (2019) observed that constriction in capillaries specifically by pericytes results from excessive NOX-4-mediated ROS generation in brain slides of humans and rats with AD.”
BackgroundConnecting the “Dots”: From Free Radical Lipid Autoxidation to Cell Pathology and Disease
Foret, M. K., Lincoln, R., Carmo, S. D., Cuello, A. C., & Cosa, G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00761 · Cited by 150
Ding, R., Hase, Y., Ameen‐Ali, K. E., Ndung'u, M., Stevenson, W., Barsby, J., Gourlay, R., Akinyemi, T. O., Akinyemi, R., Uemura, M. T., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12888 · Cited by 145
“Previous studies (42, 47) have further suggested that amyloid β is likely directly toxic to pericytes.”
BackgroundThe Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Zang, X., Chen, S., Zhu, J., Ma, J., & Zhai, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.872134 · Cited by 139
“In a mouse model of AD, pericytes are involved in Aβinduced capillary constriction in the brain (Nortley et al., 2019).”
BackgroundSun, J., Huang, Y., Gong, J., Wang, J., Fan, Y., Cai, J., Wang, Y., Qiu, Y., Wei, Y., Xiong, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19042-y · Cited by 132
Self-citationNeurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer’s disease
Zhu, W. M., Neuhaus, A. A., Beard, D. J., Sutherland, B. A., & DeLuca, G. C. (2022) · Brain · doi:10.1093/brain/awac174 · Cited by 144
“The finding from Nortley et al.(92) that Aβ1-42 causes pericytes to constrict capillaries provides a possible mechanism for the observed reduction in capillary diameter found in APP/PS1 mice.”
BackgroundMethodResultInfluentialInflammatory aspects of Alzheimer’s disease
Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 152
“In AD, aberrant deposition of Aβ leads to progressive capillary constriction [167], decreasing oxygen and blood levels, leading to neuronal loss.”
Korte, N., Ilkan, Z., Pearson, C. L., Pfeiffer, T., Singhal, P., Rock, J., Sethi, H., Gill, D., Attwell, D., & Tammaro, P. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154118 · Cited by 135
“1172/JCI154118 previously in vivo (6, 11), and capillary diameter decreased with distance from the soma, as indicated by the negative slope of the regression line differing significantly from 0 (baseline plots, Figure 7F, aCSF).”
InfluentialSelf-citationPathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives
Fisher, R. A., Miners, J. S., & Love, S. (2022) · Brain Pathology · doi:10.1111/bpa.13061 · Cited by 133
“Aβ peptides themselves are vasoactive, inducing contraction of pericytes [39] and vascular smooth muscle cells [40] which exacerbates hypoperfusion [39], and impairs BBB function [41].”
BackgroundInfluentialZhao, L., Li, Z., Vong, J. S. L., Chen, X., Lai, H. M., Yan, L. Y. C., Huang, J., Sy, S. K. H., Tian, X. Y., Huang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18249-3 · Cited by 125
Causes and consequences of baseline cerebral blood flow reductions in Alzheimer’s disease
Bracko, O., Hernández, J. C. C., Park, L., Nishimura, N., & Schaffer, C. B. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20982383 · Cited by 127
“First, a recent study showed, using human brain tissue taken from neuro-oncological biopsies, that Ab1-42 oligomers induced ROS production that led to release of endothelin-1 and constriction of capillaries via pericyte contraction, likely contributing to increased vascular resistance and thus reduced CBF (Figure 1(c)…”
BackgroundResultInfluentialNeurovascular Coupling in Development and Disease: Focus on Astrocytes
Stackhouse, T. L., & Mishra, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702832 · Cited by 132
Self-citationGullotta, G. S., Feo, D. D., Friebel, E., Semerano, A., Scotti, G. M., Bergamaschi, A., Butti, E., Brambilla, E., Genchi, A., Capotondo, A., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01505-1 · Cited by 124
Monocyte-derived IL-6 programs microglia to rebuild damaged brain vasculature
Choi, B., Johnson, K. R., Maric, D., & McGavern, D. B. (2023) · Nature Immunology · doi:10.1038/s41590-023-01521-1 · Cited by 123
Gaikwad, S., Senapati, S., Haque, M. A., & Kayed, R. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13490 · Cited by 117
“114,118 Interestingly, pericytes communicate with neurons primarily through the chemokine ligand 2, a critical component of the SASP that mediates paracrine senescence.”
BackgroundSmyth, L. C. D., Highet, B., Jansson, D., Wu, J., Rustenhoven, J., Aalderink, M., Tan, A. Y. S., Li, S., Johnson, R. H., Coppieters, N., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03180-8 · Cited by 123
Shabbir, U., Rubab, M., Tyagi, A., & Oh, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010196 · Cited by 120
An Integrated View on Vascular Dysfunction in Alzheimer’s Disease
Klohs, J. (2019) · Neurodegenerative Diseases · doi:10.1159/000505625 · Cited by 111
Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
Yeo, N. J. Y., Chan, E. J. J., & Cheung, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01363 · Cited by 120
“The role of the blood vessel in cognitive dysfunction is well described by others (Snyder et al., 2015; Sweeney et al., 2018; Nortley et al., 2019).”
BackgroundRole of the Extracellular Matrix in Alzheimer’s Disease
Sun, Y., Xu, S., Jiang, M., Liu, X., Yang, L., Bai, Z., & Yang, Q. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.707466 · Cited by 119
Brain foods - the role of diet in brain performance and health
Ekstrand, B., Scheers, N., Rasmussen, M. K., Young, J. F., Ross, A. B., & Landberg, R. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa091 · Cited by 115
Glia in neurodegeneration: Drivers of disease or along for the ride?
Gleichman, A. J., & Carmichael, S. T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104957 · Cited by 90
Sun, L., Cho, H.-J., Sen, S., Arango, A. S., Huynh, T. T., Huang, Y., Bandara, N., Rogers, B. E., Tajkhorshid, E., & Mirica, L. M. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05470 · Cited by 101
Bobola, M. S., Chen, L., Ezeokeke, C. K., Olmstead, T., Nguyen, C., Sahota, A., Williams, R. G., & Mourad, P. D. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.03.016 · Cited by 98
“Interestingly, Nortley et al [37] demonstrated that Aβ exposure constricts intra-cerebral blood 326 flow via their action on pericytes, a candidate explanation for reduced cerebral blood flow early in AD 327 progression [38] that relates a growing Aβ burden to disease progression, along with mitochondrial dysfunction…”
BackgroundA clinical primer for the glymphatic system
Carlstrom, L. P., Eltanahy, A. M., Perry, A., Rabinstein, A. A., Elder, B. D., Morris, J. M., Meyer, F. B., Graffeo, C. S., Lundgaard, I., & Burns, T. C. (2021) · Brain · doi:10.1093/brain/awab428 · Cited by 103
Alarcón-Martínez, L., Shiga, Y., Villafranca‐Baughman, D., Belforte, N., Quintero, H., Dotigny, F., Vargas, J. L. C., & Polo, A. D. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110329119 · Cited by 104
“Capillary constriction by pericytes has also been observed in brain biopsy tissue from Alzheimer’s disease (AD) patients with Aβ deposition and in a mouse model of AD (39).”
BackgroundThe Amyloid Cascade Hypothesis in Alzheimer’s Disease: Should We Change Our Thinking?
Kurkinen, M. T., Fułek, M., Fułek, K., Beszłej, J. A., Kurpas, D., & Leszek, J. (2023) · Biomolecules · doi:10.3390/biom13030453 · Cited by 105
Organ‐On‐A‐Chip Models of the Blood–Brain Barrier: Recent Advances and Future Prospects
Kawakita, S., Mandal, K., Mou, L., Mecwan, M. M., Zhu, Y., Li, S., Sharma, S., Hernández, A. L., Nguyen, H. T., Maity, S., et al. (2022) · Small · doi:10.1002/smll.202201401 · Cited by 103
Metal complexes that bind to the amyloid-β peptide of relevance to Alzheimer’s disease
Gomes, L. M., Bataglioli, J. C., & Storr, T. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213255 · Cited by 94
Blood flow, capillary transit times, and tissue oxygenation: the centennial of capillary recruitment
Østergaard, L. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00537.2020 · Cited by 99
“In brain tissue, hypoxia also stimulates the formation and retention of neurotoxic proteins (57) that, in turn, constrict pericytes (44).”
BackgroundEvolution of cellular diversity in primary motor cortex of human, marmoset monkey, and mouse
Bakken, T. E., Jorstad, N. L., Hu, Q., Lake, B. B., Tian, W., Kalmbach, B. E., Crow, M., Hodge, R. D., Krienen, F. M., Sorensen, S. A., et al. (2020) · doi:10.1101/2020.03.31.016972 · Cited by 809
Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
Wu, Y., Sonninen, T.-M., Peltonen, S., Koıstınaho, J., & Lehtonen, Š. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147710 · Cited by 91
Gullotta, G. S., Costantino, G., Sortino, M. A., & Spampinato, S. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119144 · Cited by 97
Multifaceted roles of pericytes in central nervous system homeostasis and disease
Zheng, Z., Chopp, M., & Chen, J. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20911331 · Cited by 93
“Isoforms of Apolipoprotein E (ApoE) determine the genetic risk of late-onset AD.113 Pericyte degeneration is more severe in AD ApoE4 carriers than in AD ApoE3 carriers.”
BackgroundInfluentialPresa, J., Saravia, F., Bagi, Z. A., & Filosa, J. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.584135 · Cited by 97
“ET-1, in turn, acted through ETA receptors to evoke pericyte constriction.”
BackgroundTayler, H. M., Miners, J. S., Güzel, Ö., MacLachlan, R. A., & Love, S. (2021) · Brain Pathology · doi:10.1111/bpa.12935 · Cited by 90
“Upregulation of EDN1 production by oligomeric Aβ was also shown to cause pericyte-mediated capillary vasoconstriction (16) and to alter aquaporin-4 distribution in astrocyte end-feet (49).”
BackgroundKorte, N., Barkaway, A., Wells, J. A., Freitas, F., Sethi, H., Andrews, S. P., Skidmore, J., Stevens, B., & Attwell, D. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01753-w · Cited by 100
“2b) with no change of arteriole or venule diameter 12 , the model predicted that the nimodipine-evoked 16.9% increase of the diameter of capillaries (at pericytes) and the 17.8% increase for arterioles (Fig.”
BackgroundMethodInfluentialSelf-citationApolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework
Mentis, A. A., Dardiotis, E., & Chrousos, G. P. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0731-7 · Cited by 83
“endothelin-1-mediated effects of endothelin A receptors on capillary-related pericytes [26].”
BackgroundInfluentialBracko, O., Vinarcsik, L. K., Cruz Hernández, J. C., Ruiz-Uribe, N. E., Haft-Javaherian, M., Falkenhain, K., Ramanauskaite, E. M., Ali, M., Mohapatra, A., Swallow, M. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65908-y · Cited by 85
Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid
Albrecht, D., Isenberg, A. L., Stradford, J., Monreal, T. K., Sagare, A. P., Pachicano, M., Sweeney, M. D., Toga, A. W., Zloković, B. V., Chui, H. C., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1230-20.2020 · Cited by 87
“A tau-independent pathway is supported by recent evidence that amyloid deposits act directly on pericytes to reduce CBF through pericyte-mediated capillary constriction (Nortley et al., 2019).”
In vivo methods for imaging blood–brain barrier function and dysfunction
Harris, W. J., Asselin, M., Hinz, R., Parkes, L. M., Allan, S. M., Schießl, I., Boutin, H., & Dickie, B. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05997-1 · Cited by 91
Neurovascular dysfunction in glaucoma
Alarcón-Martínez, L., Shiga, Y., Villafranca‐Baughman, D., Vargas, J. L. C., Vidal-Paredes, I. A., Quintero, H., Fortune, B. A., Danesh-Meyer, H. V., & Polo, A. D. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2023.101217 · Cited by 89
Neuropathological assessment of the Alzheimer spectrum
Jellinger, K. A. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02232-9 · Cited by 85
Nelson, A. R., Sagare, M. A., Wang, Y., Kisler, K., Zhao, Z., & Zlokovic, B. V. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00108 · Cited by 73
“, 2019); and in vivo studies in rodents (see Table 3 for details; Dai et al., 2009, 2011; Fernández-Klett et al., 2010; Hall et al., 2014; Hill et al., 2015; Biesecker et al., 2016; Mishra et al., 2016; Nelson et al., 2016; Wei et al., 2016; Bertlich et al., 2017; Kisler et al., 2017b; Hartmann et al., 2018; Khennouf…”
BackgroundResultInfluentialMicrovascular Alterations in Alzheimer's Disease
Steinman, J., Sun, H., & Feng, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.618986 · Cited by 85
“These findings suggest the microvasculature could contribute to damage of brain cells and synapses (Nortley et al., 2019).”
BackgroundCan exercise training teach us how to treat Alzheimer's disease?
Huuha, A. M., Norevik, C. S., Moreira, J. B. N., Kobro-Flatmoen, A., Scrimgeour, N., Kivipelto, M., Van Praag, H., Ziaei, M., Sando, S. B., Wisløff, U., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101559 · Cited by 79
Uekawa, K., Hattori, Y., Ahn, S. J., Seo, J., Casey, N., Anfray, A., Zhou, P., Luo, W., Anrather, J., Park, L., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00660-1 · Cited by 80
“No-reflow” phenomenon in acute ischemic stroke
Zhang, Y., Jiang, M., Gao, Y., Zhao, W., Wu, C., Li, C., Ming, L., Wu, D., Wang, W., & Ji, X. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231208476 · Cited by 98
“87 Given that ROS is also prevalent in I/R injury, this signaling pathway might contribute to pericyte contraction in “no-reflow”, which warrants further investigation.”
BackgroundBrain amyloid and vascular risk are related to distinct white matter hyperintensity patterns
Pålhaugen, L., Sudre, C. H., Tecelao, S., Nakling, A., Almdahl, I. S., Kalheim, L. F., Cardoso, M. J., Johnsen, S. H., Rongve, A., Aarsland, D., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20957604 · Cited by 79
Lemon, N. L., Canepa, E., Ilies, M. A., & Fossati, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.772278 · Cited by 85
Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow
Dolui, S., Detre, J. A., Gaussoin, S. A., Herrick, J. S., Wang, D. J. J., Tamura, M. K., Cho, M. E., Haley, W. E., Launer, L. J., Punzi, H. A., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0074 · Cited by 76
Jurcău, M. C., Jurcău, A., Cristian, A., Hogea, V. O., Diaconu, R. G., & Nunkoo, V. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910535 · Cited by 100
“In addition, pericytes clear A β through receptor-mediated endocytosis, involving the low-density receptor-related protein 1 (LRP1), a function altered by age-related dysfunction and loss of pericytes [207].”
BackgroundVisible‐Light‐Induced Cysteine‐Specific Bioconjugation: Biocompatible Thiol–Ene Click Chemistry
Choi, H., Kim, M., Jang, J., & Hong, S. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202010217 · Cited by 80
Li, P., & Fan, H. (2023) · Cells · doi:10.3390/cells12151931 · Cited by 81
Ting, K. K., Coleman, P. R., Kim, H. J., Zhao, Y., Mulangala, J., Cheng, N. C., Li, W., Gunatilake, D., Johnstone, D. M., Loo, L., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00927-x · Cited by 81
Wu, Y., Bogale, T. A., Koıstınaho, J., Pizzi, M., Rõlova, T., & Bellucci, A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02696-z · Cited by 82
“Moreover, A β has been discovered to induce pericyte-mediated constriction of brain capillaries through the upregulation of endothelin-1 release, which is mediated by the overproduction of ROS [98].”
BackgroundSang, Z., Wang, K., Shi, J., Liu, W., Cheng, X., Zhu, G., Wang, Y., Zhao, Y., Qiao, Z., Wu, A., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112180 · Cited by 77
Nitric oxide is fundamental to neurovascular coupling in humans
Hoiland, R. L., Caldwell, H. G., Howe, C. A., Nowak‐Flück, D., Stacey, B. S., Bailey, D. M., Paton, J. F. R., GREEN, D. J., Sekhon, M. S., MacLeod, D. B., et al. (2020) · The Journal of Physiology · doi:10.1113/jp280162 · Cited by 83
More than just summed neuronal activity: how multiple cell types shape the BOLD response
Howarth, C., Mishra, A., & Hall, C. N. (2020) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0630 · Cited by 87
Self-citationAcute Ablation of Cortical Pericytes Leads to Rapid Neurovascular Uncoupling
Kisler, K., Nikolakopoulou, A. M., Sweeney, M. D., Lazić, D., Zhao, Z., & Zloković, B. V. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00027 · Cited by 73
“Our group and others have shown that pericytes play vital roles in regulation of CBF (Bell et al., 2010; Tachibana et al., 2018; Nikolakopoulou et al., 2019; Nortley et al., 2019), neurovascular coupling (Peppiatt et al.”
BackgroundResultInfluentialNeurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors
Lecordier, S., Manrique‐Castano, D., Moghrabi, Y. E., & ElAli, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.727590 · Cited by 78
“Furthermore, vascular functional impairments are featured by BBB dysfunction caused by loss of endothelial cells, deregulation of mural cells mediated by oligomeric Aβ accumulation, as well as induction of astrocytosis with dystrophic endfeet surrounding BM Aβ deposits (Shimizu et al., 2009; de Jager et al., 2013; Gia…”
BackgroundKyrargyri, V., Madry, C., Rifat, A., Arancibia‐Cárcamo, I. L., Jones, S. P., Chan, V. T. T., Xu, Y., Robaye, B., & Attwell, D. (2019) · Glia · doi:10.1002/glia.23719 · Cited by 69
“Hippocampal slices from older animals (>2 months old) were prepared using two different solutions (Nortley et al., 2019; Ting, Daigle, Chen, & Feng, 2014), a protective NMDG slicing solution containing (mM) 93 N-methyl-Dglucamine (NMDG), 93 HCl, 20 HEPES, 30 NaHCO3, 2.5 KCl, 0.5 CaCl2, 10 MgCl2,…”
MethodInfluentialSelf-citationYue, Q., & Hoi, M. P. M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.367832 · Cited by 78
“In addition, Aβ-evoked ET-1 release activated pericyte endothelin-A receptor (ET-A) causing capillary constriction and pericyte death (Nortley et al., 2019).”
Metadata
- Authors
- Nortley, R., Korte, N., Izquierdo, P., Hirunpattarasilp, C., Mishra, A., Jaunmuktane, Z., Kyrargyri, V., Pfeiffer, T., Khennouf, L., Madry, C., Gong, H., Richard-Loendt, A., Huang, W., Saito, T., Saido, T. C., Brandner, S., Sethi, H., & Attwell, D.
- Affiliations
- University College London (GB)
- Oregon Health & Science University (US)
- National Hospital for Neurology and Neurosurgery (GB)
- Saarland University (DE)
- RIKEN Center for Brain Science (JP)
- UCL Queen Square Institute of Neurology (GB)
- Corresponding author
- Korte, Nils
- Izquierdo, Pablo
- Hirunpattarasilp, Chanawee
- Mishra, Anusha
- Jaunmuktane, Zane
- Kyrargyri, Vasiliki
- Attwell, David
- ORCID
- Venue
- Science
- Published
- 2019-07-19
- Volume
- 365
- Issue
- 6450
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6658218
- OpenAlex
- W2951514146
- Semantic Scholar
- cc2df1df8221a1fa3d428338a5ead55bc1a47948
- Cited by
- 682
- References
- 53
- Citations by year
- 2026: 64 · 2025: 90 · 2024: 105 · 2023: 108 · 2022: 93 · 2021: 102 · 2020: 102 · 2019: 16
- FWCI
- 34.70
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust (099222, PhD studentship)
- European Research Council (BrainPower & BrainEnergy)
- Deutsche Forschungsgemeinschaft (KI 503/14-1 and SFB894)
- EMBO (Fellowship)
- Lundbeckfonden (Fellowship)
- national institute of health research (Biomedical Research Centre)
- Leonard Wolfson Experimental Neurology Centre (PhD studentship)
- BBSRC (PhD studentship)
- Chulabhorn Royal Academy (PhD studentship)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta oligomers, Alzheimer's disease, pericytes, brain capillaries, cerebral blood flow, vasoconstriction, mouse models of Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Animals, Hypoxia, Biopsy, Capillaries, Cerebral Cortex, Cerebrovascular Circulation, Constriction, Pathologic, Humans, Vascular Resistance, Signal Transduction, Amyloid beta-Peptides, Rats, Sprague-Dawley, Reactive Oxygen Species, Endothelin-1, Pericytes, Receptor, Endothelin A, Mice, Rats, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
